Enterome
Christelle Dumoussaud has an extensive work experience spanning over several companies and roles. Christelle served as the Chief Financial Officer at Enterome in 2016. Prior to that, they worked as an Interim Manager at ADPI - Member company of AEROPORTS DE PARIS GROUP in 2015. In 2014, they held the position of General Secretary at Laboratoire Dermophil Indien and also worked as an Interim Manager at ADPI - Member company of AEROPORTS DE PARIS GROUP. From 2012 to 2013, they worked as a Financial Advisor at Almavia - filiale du Groupe Nextedia. Christelle served as the Chief Financial Officer and HR Manager France & Belgium at Polygon from 2007 to 2012. Before that, they worked as a Project Manager at Solvay from 2005 to 2007. In 2001, they held the position of Chief Financial Officer Belgium at Fournier Pharma and prior to that, they worked as a Financial Controller at the same company from 1997 to 2001. Christelle started their career as a Business Analyst at Brossard - Groupe Sara Lee in 1995 and later worked as a Sales Support Analyst at Well - Groupe Courtaulds Textile from 1994 to 1995.
Christelle Dumoussaud attended Lycée Michel Montaigne from 1989 to 1990, where they completed a preparatory year for "Grandes Ecoles." From 1990 to 1993, they studied at ISC Paris and obtained a Master of Business Management degree with a specialization in Audit and Control.
Enterome
Enterome’s OncoMimic technology allows the overcoming of immune tolerance against cancer cells, with broad applicability against solid tumor via an off-the-shelf, easy to manufacture technology. Enterome’s potentially first-in-class small protein and peptide drug candidates modulate the immune system by closely mimicking the structure, effect oractions of Tumor Associated Antigens to induce a potent, endogenous CD8 T cell response. The company’s most advanced programs are in Phase 2 clinical trials in hard-to-treat tumors such as glioblastoma, adrenal malignancies and colorectal cancer.